Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
about
A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorderSystematic review of the neural basis of social cognition in patients with mood disorders.Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.Identifying risk for attrition during treatment for depression.Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsThe relationship between symptom relief and psychosocial functional improvement during acute electroconvulsive therapy for patients with major depressive disorderAugmenting antidepressant medication treatment of depressed women with emotionally focused therapy for couples: a randomized pilot study.Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder.Use of psychotherapy for depression in older adultsSuicide prevention is far more than a psychiatric business.Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.Developmental relations between perceived social support and depressive symptoms through emerging adulthood: blood is thicker than water.The impact of individual depressive symptoms on impairment of psychosocial functioning.Antidepressants and psychotherapy: a clinical research reviewPoor response to treatment: beyond medication.Towards achieving remission in the treatment of depression.Depression sum-scores don't add up: why analyzing specific depression symptoms is essentialImprovement in social-interpersonal functioning after cognitive therapy for recurrent depression.A randomized clinical trial of a telephone depression intervention to reduce employee presenteeism and absenteeismImpact of socioeconomic status and subjective social class on overall and health-related quality of life.Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in DepressionComparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.General principles of migraine management: the changing role of prevention.Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorderPrimary care patients' personal illness models for depression: relationship to coping behavior and functional disability.Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.Managing depression-related occupational disability: a pragmatic approach.Long-term social functioning after depression treated by psychiatrists: a review.Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends.Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depressionPsychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.Patient-reported functioning in major depressive disorder.Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
P2860
Q24564427-70E426B7-940E-4E77-AC72-F9013AA7A68CQ30467590-1F10E812-F3B4-4215-A6EE-A0EC8709FCA9Q33540887-C946EF16-BAC7-4993-86F1-5AC14B06243CQ33622133-6A049478-2DF9-487E-A1E8-0F406DF7D2C0Q33646530-637A6E1C-D81B-4D22-A8DF-C83CFE81443DQ33718213-5BF53F97-A5F4-48BD-B414-234A856A250FQ33858269-FDD04709-45EC-47ED-94D4-AA6B74AB2E5DQ33918503-37926885-BF72-45A5-9B08-360130CF181DQ34024116-E477BC1E-A3E2-48A1-A6EA-04DBC19A3DB3Q34066966-3104DE0D-C30B-4B2E-8915-C8DC7C89BEA2Q34481967-FB034098-CF9A-4427-9114-4A660BC30A5FQ34672417-1BD52CC5-5680-481E-B526-CDE9182ADC94Q34713784-22C01AD9-907E-41EC-8487-A6C49CDF6B14Q34816887-71D79B1D-834F-4833-AB63-96FC25852CA0Q35108943-BD513BFA-1141-4A84-9764-C31A06C89A44Q35236625-6BDCF00C-47C0-4EF4-A7C2-0AE0A4EA6426Q35236765-C94E51E5-9595-483C-A786-A8F60B4B86B3Q35237032-2F9E7A8E-A254-446F-9D37-AE0634E03A1BQ35276531-4DDCC715-F890-4247-8935-A4600D28143DQ35546857-0A01EA2D-DC3A-49CF-BDFA-E99EE5089340Q35671677-AECEEDF7-3EE8-4DB6-9CDE-852250397455Q35746780-0D8F20A8-7E48-4AFF-A31E-5AD34DD8AE9DQ35858540-4D9E7BE3-0126-426A-8343-92DB9EA1189EQ36007894-25D70AD3-C01E-4BDD-A42B-7CBD09338512Q36083249-37A9AF6F-A9A1-43D3-86ED-0659F0DDEFF7Q36099512-C28DA22F-DC7D-4B37-A81B-E86CBDDBD005Q36208461-4D267222-D7B5-4F10-A770-6E8A2CF806F7Q36234571-95151EDB-17FC-4E37-A264-158A705A941FQ36366194-C1977CC4-FF71-4908-A4D4-C63E8504F5A9Q36502991-BFB57FB6-BFD0-444C-957F-750181BDDF42Q36514336-D07F7DE5-98AE-4185-8C95-2D86EB0F4A8BQ36600040-15845F92-A820-4B69-8E79-CD8E85EB209EQ36772958-4BBB7D42-9EF1-481F-8545-6501F3849BC2Q36795003-D74F1831-CBB2-4449-BAAA-BB633BA08915Q36889128-864D38E8-58C7-46E8-9B6F-52EBD3EEAEF0Q36942348-7BB11470-3177-4381-BB8B-E34F63ED6B83Q36995148-0495E10E-B8A3-4287-A613-AA33C012C3B3Q37002114-603103C3-CCF0-423F-8F8B-C686E9303A8EQ37035331-FF9D78F7-C5E0-487B-B79E-860FF61A80B2Q37144258-2DEF8726-F79B-477D-8A44-623D2AC6E8D8
P2860
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Does psychosocial functioning ...... herapy, and their combination.
@en
Does psychosocial functioning ...... herapy, and their combination.
@nl
type
label
Does psychosocial functioning ...... herapy, and their combination.
@en
Does psychosocial functioning ...... herapy, and their combination.
@nl
prefLabel
Does psychosocial functioning ...... herapy, and their combination.
@en
Does psychosocial functioning ...... herapy, and their combination.
@nl
P2093
P1476
Does psychosocial functioning ...... herapy, and their combination.
@en
P2093
A John Rush
Alan F Schatzberg
Charles B Nemeroff
Daniel N Klein
David L Dunner
Frances E Borian
Gabor Keitner
Ivan Miller
John C Markowitz
Lorrin M Koran
P304
P356
10.1016/S0006-3223(01)01291-4
P407
P50
P577
2002-01-01T00:00:00Z